Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I
Department of Pediatrics, School of Medicine, Totaki University, Kanagawa, Japan.
Tokai J Exp Clin Med. 1988;13 Suppl:15-9.
Japanese clinical trials with Takeda acellular pertussis vaccine revealed that infants 3 to 8 months of age reacted sufficiently to the vaccine: anti-PT ant-FHA levels after vaccination were as high as those observed with 2 year old children. No substantial difference in general reactions was noted between infants and 2 year old children. Less local reactions were noted in infants.
武田无细胞百日咳疫苗的日本临床试验表明，3至8个月大的婴儿对该疫苗反应充分：接种疫苗后的抗百日咳毒素（anti-PT）和抗丝状血凝素（ant-FHA）水平与2岁儿童的水平一样高。婴儿和2岁儿童在一般反应方面没有显著差异。婴儿出现的局部反应较少。
